Liraglutide for the treatment of obesity among patients with hidradenitis suppurativa
CONCLUSIONS: Liraglutide 3mg is effective and safe among patients with HS and obesity. Long-term studies are mandatory to assess the effects of liraglutide on skin lesions and inflammatory markers among subjects with HS beyond weight loss.PMID:38044187 | DOI:10.1016/j.medcli.2023.11.007
Source: Medicina Clinica - Category: General Medicine Authors: Joana Nicolau Antoni Nadal Pilar Sanch ís Antelm Pujol Llu ís Masmiquel Cristina Nadal Source Type: research
More News: Dermatology | Eating Disorders & Weight Management | General Medicine | Hidradenitis | Obesity | Skin | Study | Victoza | Weight Loss